Cue Advisory Services’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-3,654
Closed -$359K 80
2018
Q3
$359K Sell
3,654
-34
-0.9% -$3.14K 0.22% 126
2018
Q2
$316K Sell
3,688
-180
-5% -$15K 0.19% 132
2018
Q1
$310K Buy
3,868
+148
+4% +$12.2K 0.2% 128
2017
Q4
$300K Sell
3,720
-1,914
-34% -$153K 0.2% 135
2017
Q3
$438K Buy
5,634
+394
+8% +$32.7K 0.3% 114
2017
Q2
$465K Buy
5,240
+39
+0.7% +$3.29K 0.33% 103
2017
Q1
$419K Hold
5,201
0.32% 106
2016
Q4
$370K Buy
5,201
+900
+21% +$70.7K 0.3% 110
2016
Q3
$372K Buy
4,301
+35
+0.8% +$3.05K 0.31% 104
2016
Q2
$370K Hold
4,266
0.32% 104
2016
Q1
$320K Buy
4,266
+20
+0.5% +$1.51K 0.28% 108
2015
Q4
$327K Buy
+4,246
New +$320K 0.29% 107

Other funds holding MDT

Cue Advisory Services's MDT Position: Q4 2018 in Review

Cue Advisory Services sold out of Medtronic (MDT) in Q4 2018, closing a stake of 3,654 shares — an estimated $359K sold.

Cue Advisory Services first reported a position in MDT in Q4 2015 and held it in 12 quarters. The position peaked at $465K in Q2 2017. 1,564 funds tracked by Wall St. Rank hold MDT as of Q4 2018.

  • Cue Advisory Services reported no remaining Medtronic position as of Q4 2018 after selling out during the quarter.
  • Cue Advisory Services sold 3,654 Medtronic shares in Q4 2018, an estimated $359K.
  • Cue Advisory Services first reported a position in Medtronic in Q4 2015 and held it in 12 quarters.
  • Cue Advisory Services's Medtronic position peaked at $465K in Q2 2017.
  • 1,564 funds tracked by Wall St. Rank held Medtronic as of Q4 2018.

Based on Cue Advisory Services's 13F filing for Q4 2018.